Literature DB >> 9792578

Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea.

R Jokic1, A Klimaszewski, G Sridhar, M F Fitzpatrick.   

Abstract

OBJECTIVES: (1) To compare the continuous positive airway pressure (CPAP) requirement at the time of diagnosis (T0), after 2 weeks (T2), and after 4 weeks (T4) of CPAP treatment, in patients with severe obstructive sleep apnea (OSA); and (2) to assess whether any alteration in CPAP requirement over the first 4 weeks of CPAP treatment would influence daytime alertness, subjective sleepiness, or mood.
DESIGN: A prospective, controlled, single-blind crossover study.
SETTING: University teaching hospital. PATIENTS: Ten patients with newly diagnosed and previously untreated severe OSA (aged 52+/-9 years, apnea hypopnea index [AHI] of 99+/-31) and subsequently 10 control patients (aged 52+/-11 years, AHI 85+/-17). MEASUREMENTS: Overnight polysomnography with CPAP titration to determine the CPAP requirement, which was standardized for body position and sleep stage, on all three occasions (T0, T2, T4). Objective sleep quality, daytime alertness, subjective sleepiness (Epworth Sleepiness Scale), and mood (Hospital Anxiety and Depression Scale).
RESULTS: CPAP requirement decreased from T0 to T2 (median difference, 1.5 cm H2O, 95% confidence interval [CI], 1.1 to 2.7 cm H2O, p=0.0004) and did not differ between T2 and T4. Use of the lower CPAP pressure during T2 to T4 was associated with a decrease in Epworth scale (mean difference, 2.6, 95% CI, 1.2 to 4; p=0.01) and anxiety (median change, 2; 95% CI, 0.5 to 2.9, p=0.03) scores, as compared with the first 2 weeks. Daytime alertness did not differ between T0 to T2 and T2 to T4.
CONCLUSION: CPAP requirement falls within 2 weeks of starting CPAP treatment. A change to the lower required CPAP was not associated with any deterioration in daytime alertness but was associated with small subjective improvements in sleepiness and mood.

Entities:  

Mesh:

Year:  1998        PMID: 9792578     DOI: 10.1378/chest.114.4.1061

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Guidelines for diagnosing and treating sleep related breathing disorders in adults and children (Part 2: treatment).

Authors:  V Tsara; A Amfilochiou; M J Papagrigorakis; D Georgopoulos; E Liolios; C Alexopoulou; C Maniou; P Kithreotis; G Trakada; F Synodinos; G Vilos; P Steiropoulos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

2.  Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea.

Authors:  Ritu G Grewal
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

Review 3.  [Update on therapy with positive airway pressure in sleep-related breathing disorders].

Authors:  N Stasche
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

4.  Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.

Authors:  Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley
Journal:  J Clin Sleep Med       Date:  2008-04-15       Impact factor: 4.062

5.  Selective indication for positive airway pressure (PAP) in sleep-related breathing disorders with obstruction.

Authors:  Norbert Stasche
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.